KMTS Kestra Medical Technologies Ltd.

  1. Stocks
  2. Healthcare
  3. NASDAQ: KMTS

Price (delayed)

$21.06

Market cap

$1.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.43

Enterprise value

$1.18B

?
Relative Growth: Rel. Growth: 80
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 18

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and ...

Highlights
The gross profit has soared by 102% year-on-year and by 20% since the previous quarter
Kestra Medical Technologies's revenue has surged by 59% YoY and by 14% QoQ
KMTS's equity is up by 26% year-on-year but it is down by 10% since the previous quarter
Kestra Medical Technologies's net income has decreased by 16% YoY but it has increased by 9% from the previous quarter
Kestra Medical Technologies's quick ratio has decreased by 41% QoQ and by 35% YoY
Kestra Medical Technologies's debt has increased by 6% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://kestramedical.com
Peers: ABT MDT BDX ISRG

Key stats

What are the main financial stats of KMTS

KMTS stock price

How has the Kestra Medical Technologies stock price performed over time
Intraday
-2.36%
1 week
-13.76%
1 month
-4.62%
1 year
24.1%
YTD
-20.59%
QTD
-17.22%

Financial performance

How have Kestra Medical Technologies's revenue and profit performed over time
Revenue
$95.13M
Gross profit
$48.86M
Operating income
-$134.74M
Net income
-$131.61M
Gross margin
51.4%
Net margin
-138.4%
The gross profit has soared by 102% year-on-year and by 20% since the previous quarter
Kestra Medical Technologies's revenue has surged by 59% YoY and by 14% QoQ
KMTS's operating income is down by 27% year-on-year but it is up by 6% since the previous quarter
Kestra Medical Technologies's net margin has increased by 27% YoY and by 19% from the previous quarter

Price vs fundamentals

How does KMTS's price correlate with its fundamentals

Growth

What is Kestra Medical Technologies's growth rate over time

Valuation

What is Kestra Medical Technologies stock price valuation
P/E
N/A
P/B
4.73
P/S
12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.4
Kestra Medical Technologies's EPS has surged by 53% YoY and by 27% QoQ
KMTS's equity is up by 26% year-on-year but it is down by 10% since the previous quarter
The price to book (P/B) is 17% lower than the last 4 quarters average of 5.7
Kestra Medical Technologies's revenue has surged by 59% YoY and by 14% QoQ
The stock's price to sales (P/S) is 20% less than its last 4 quarters average of 15.0

Efficiency

How efficient is Kestra Medical Technologies business performance
KMTS's return on invested capital is up by 48% year-on-year and by 44% since the previous quarter
The company's return on assets rose by 43% YoY and by 16% QoQ
Kestra Medical Technologies's return on sales has increased by 27% YoY and by 20% QoQ
Kestra Medical Technologies's ROE has increased by 16% from the previous quarter

Dividends

What is KMTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KMTS.

Financial health

How did Kestra Medical Technologies financials performed over time
Kestra Medical Technologies's quick ratio has decreased by 41% QoQ and by 35% YoY
The current ratio is down by 40% since the previous quarter and by 34% year-on-year
Kestra Medical Technologies's debt is 82% less than its equity
KMTS's equity is up by 26% year-on-year but it is down by 10% since the previous quarter
The debt to equity is down by 18% YoY but it is up by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.